Bimatoprost as a Treatment for Graves' Orbitopathy

Recruiting now · Early Phase 1

Conditions studied: Graves Ophthalmopathy

In brief

Testing whether Bimatoprost, a topical eye drop used for glaucoma, can be used to induce periorbital fat atrophy in patients with Graves' disease

Key facts

Study ID

NCT03708627

Run by

Johns Hopkins University

People needed

3

Starts

2017-11-01

Expected to finish

2031-07-01

Last updated by the study team

2026-07-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Washington — Seattle, Washington, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.